about
Ceruloplasmin activity and iron chelation treatment of patients with Parkinson's disease.Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial.A diagnostic scale for Alzheimer's disease based on cerebrospinal fluid biomarker profiles.Duplication at chromosome 2q31.1-q31.2 in a family presenting syndactyly and nystagmus.Absence of unidentified CAG repeat expansion in patients with Huntington's disease-like phenotypeCerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study.Microtubule-associated protein tau gene: a risk factor in human neurodegenerative diseases.Mis-splicing of Tau exon 10 in myotonic dystrophy type 1 is reproduced by overexpression of CELF2 but not by MBNL1 silencing.Altered splicing of Tau in DM1 is different from the foetal splicing process.Tau as a biomarker of neurodegenerative diseases.ETR-3 represses Tau exons 2/3 inclusion, a splicing event abnormally enhanced in myotonic dystrophy type I.Alternative promoter usage generates novel shorter MAPT mRNA transcripts in Alzheimer's disease and progressive supranuclear palsy brains.Real time RT-PCR shows correlation between retinoid-induced apoptosis and NGF-R mRNA levels.TMEM240 mutations cause spinocerebellar ataxia 21 with mental retardation and severe cognitive impairment.Mutation analysis and association studies of the ubiquitin carboxy-terminal hydrolase L1 gene in Huntington's disease.Symptomatic hyperlactataemia: an emerging complication of antiretroviral therapy.Insights into genotype-phenotype correlations in spinal muscular atrophy: a retrospective study of 103 patients.Association of corticobasal degeneration and Huntington's disease: can Tau aggregates protect Huntingtin toxicity?A genetic variation in the ADORA2A gene modifies age at onset in Huntington's disease.RNF216 mutations as a novel cause of autosomal recessive Huntington-like disorder.The p.Asp216His TOR1A allele effect is not found in the French population.Dopa-decarboxylase gene polymorphisms affect the motor response to L-dopa in Parkinson's disease.The MAPT gene is differentially methylated in the progressive supranuclear palsy brain.Reply: Cognition in SCA21 reflects developmental and adult onset cerebellar cognitive affective syndrome.Overexpression of MBNL1 fetal isoforms and modified splicing of Tau in the DM1 brain: two individual consequences of CUG trinucleotide repeats.Impact of harmonization of collection tubes on Alzheimer's disease diagnosis.A new decision tree combining Abeta 1-42 and p-Tau levels in Alzheimer's diagnosis.[Molecular actors in Alzheimer's disease: which diagnostic and therapeutic consequences?].Slowly progressive spinocerebellar ataxia with extrapyramidal signs and mild cognitive impairment (SCA21)A new locus for spinocerebellar ataxia (SCA21) maps to chromosome 7p21.3-p15.1Clinical features and genetic analysis of a new form of spinocerebellar ataxiaNIPA1 (SPG6) mutations are a rare cause of autosomal dominant spastic paraplegia in EuropeIs the early-onset torsion dystonia (EOTD) linked to TOR1A gene as frequent as expected in France?Critical Role of Tyrosine 277 in the Ligand-Binding and Transactivating Properties of Retinoic Acid Receptor α†Synthesis of a biospecific adsorbent for the purification of the three human retinoic acid receptors by affinity chromatographyAssociation of the glucocorticoid receptor binding subunit with the 90K nonsteroid-binding component is stabilized by both steroidal and nonsteroidal antiglucocorticoids in intact cellsImproved Stokes radius measurement of the glucocorticoid receptor using TSK G4000SW and TSK G3000SW high-performance size-exclusion columns. Analytical and preparative applicationsPhysical characterization of the activated and non-activated forms of the glucocorticoid-receptor complex bound to the steroid antagonist [3H]RU 486Inactivation of unbound rat liver glucocorticoid receptor by N-alkylmaleimides at sub-zero temperaturesPhysicochemical parameters affecting the charcoal adsorption assay for quantitative retinoid-binding measurement
P50
Q30944822-B6428B87-7E6A-4E41-94CB-94DAD233D6C3Q34278569-6503535B-AF5A-4899-B1F9-B6660A3BA1D9Q34630534-682671A8-35E4-41E6-84A6-5BAB2262FAB6Q35406305-A6EAADDE-0EA1-41D8-A3AD-88FD5BF6EBA7Q35456931-619643BE-902C-47C6-974B-922BDE34F7EBQ35669559-F11C5EF8-2D85-4734-8C56-5C79871CB875Q35729345-A5002F10-C91D-4D7C-84B8-C466B784F03AQ38336368-33FE510E-535C-4B45-90C6-CDF4207A9D0CQ39891392-BFCA183B-4DC9-4671-8399-712DD13D146EQ40065021-3BA8AF69-5AB2-48DF-859C-537A603C23E3Q40252149-3B96A017-0F10-4E90-A01E-746E3BFF5703Q42106758-A47FD743-B8FA-43E7-8F3F-A9143673F0ECQ42513491-4D69CE0C-04F4-4CC2-8960-A590B187380DQ43736766-F7F8AB43-1A28-443D-90F8-90A9A9BE1133Q44068407-7D7D1015-504A-4615-B9C4-FFC2948F8891Q44465627-E596AAB9-8CDD-40A9-8C9C-C5ECCE40B72DQ44844914-2BBB82F5-3C73-4160-AEAE-E04DF18767C5Q45292769-D8F0F806-3085-4AAC-A0E0-D60051AE771EQ45294471-116006EF-76D3-4BF2-9EC9-B6CDB4B77C64Q45305091-80170BE8-BD26-4C21-8B6A-744C4ACFA975Q46101096-1F48F8ED-C7B1-468F-A197-CD1A93BE3B69Q46407825-1348B625-CCB3-4E4E-B42D-C9E318BA86B3Q47920677-4FDE4E12-2150-49A2-9AE4-466B1EA32C3AQ48381209-83EDDF64-350B-4599-86D7-02A69A74F04EQ50651329-866DCC56-101E-4B1C-ACCC-919BDEB9E77DQ50871001-212047E7-155F-4CFA-8FE4-6CADB59A7583Q50904596-20720F72-FA6F-4349-AF15-A7D44DF1080AQ53419341-981A2826-5D12-47CA-9C94-FA307F2FF629Q57667106-2CA8D008-F697-46DE-B6FD-13940A73BAF8Q57667221-B473295E-1EB6-49DB-8BC6-E9D6C77076FDQ57667246-C6534DE4-F539-4A8D-8E94-382D5F7049F7Q57970896-F5DF35F9-DCC8-4BA5-9EDE-61334CC3E1B9Q59526238-DE455E43-4747-40CE-8132-7053268AD360Q62662407-437C30FF-A863-4626-AC0C-7BC8C9C52AE2Q67503995-3548B298-4114-4F58-93C5-6AB9511086BEQ68061024-08655A7A-16C4-4770-8021-71CBBC5E3A7CQ69448048-EBF92282-1E0D-4F64-9BD9-8667D9E787F0Q69700654-66477B2E-77F9-4C7A-B17B-98D94B5280C5Q70816699-A4863C4B-8DD0-487B-92E1-E8CEB2F6A88EQ71626315-33A3F4CE-9CB9-4D3E-BD05-33B4A1B53958
P50
description
researcher ORCID ID = 0000-0003-0384-4076
@en
wetenschapper
@nl
name
Bernard Sablonniere
@ast
Bernard Sablonniere
@en
Bernard Sablonniere
@es
Bernard Sablonniere
@nl
type
label
Bernard Sablonniere
@ast
Bernard Sablonniere
@en
Bernard Sablonniere
@es
Bernard Sablonniere
@nl
prefLabel
Bernard Sablonniere
@ast
Bernard Sablonniere
@en
Bernard Sablonniere
@es
Bernard Sablonniere
@nl
P106
P1153
55913527500
P31
P496
0000-0003-0384-4076